David Brailer - Walgreens Boots Independent Director
WBA Stock | USD 21.02 0.51 2.49% |
Director
Dr. David J. Brailer M.D., Ph.D. serves as Independent director of Walgreens boots alliance, inc. He is Chairman of Health Evolution Partners, a private equity firm focused on the healthcare industry, since 2006. He served as National Coordinator for Health Information Technology within the Department of Health and Human Services of the U.S. federal government from May 2004 to April 2006. He was a Senior Fellow at the Health Technology Center from 2002 to 2004. Previously, he served as Chairman and Chief Executive Officer and a director of CareScience, Inc., a provider of care management services and Internetbased healthcare solutions, from 1992 to 2002. Prior to that, he was Adjunct Assistant Professor of Health Care Systems at The Wharton School of Business at the University of Pennsylvania. He serves on the boards of directors of several private companies in the healthcare sector.
Age | 58 |
Address | 108 Wilmot Road, Deerfield, IL, United States, 60015 |
Phone | 847 315 3700 |
Web | https://www.walgreensbootsalliance.com |
Walgreens Boots Management Efficiency
The company has Return on Asset of 0.0132 % which means that on every $100 spent on assets, it made $0.0132 of profit. This is way below average. Walgreens Boots' management efficiency ratios could be used to measure how well Walgreens Boots manages its routine affairs as well as how well it operates its assets and liabilities. The current year's Return On Capital Employed is expected to grow to -0.1. The current year's Return On Assets is expected to grow to -0.03. At present, Walgreens Boots' Total Assets are projected to increase significantly based on the last few years of reporting. The current year's Non Current Assets Total is expected to grow to about 98 B, whereas Total Current Assets are forecasted to decline to about 9.2 B.Similar Executives
Showing other executives | DIRECTOR Age | ||
Susan Kropf | Kroger Company | 71 | |
Michelle Gloeckler | BJs Wholesale Club | 53 | |
Mark Sutton | Kroger Company | 59 | |
Timothy McGuire | Dollar General | 60 | |
Clyde Moore | Kroger Company | 66 | |
Gregory Bridgeford | Dollar Tree | 62 | |
Edward Cerkovnik | Natural Grocers By | 63 | |
Richard Halle | Natural Grocers By | 56 | |
Thomas Saunders | Dollar Tree | 80 | |
Karen Hoguet | Kroger Company | 63 | |
Robert Steele | BJs Wholesale Club | 65 | |
Ashok Vemuri | Kroger Company | 52 | |
Michael Campbell | Natural Grocers By | 73 | |
Ting Tan | WEBUY GLOBAL LTD | 29 | |
Anne Gates | Kroger Company | 61 | |
Bobby Shackouls | Kroger Company | 68 | |
Christopher Stadler | BJs Wholesale Club | 53 | |
Patricia FiliKrushel | Dollar General | 67 | |
Arnold Barron | Dollar Tree | 69 | |
Jeffrey Naylor | Dollar Tree | 59 | |
Ray Compton | Dollar Tree | 81 |
Management Performance
Return On Equity | 4.0E-4 | ||||
Return On Asset | 0.0132 |
Walgreens Boots Alliance Leadership Team
Elected by the shareholders, the Walgreens Boots' board of directors comprises two types of representatives: Walgreens Boots inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Walgreens. The board's role is to monitor Walgreens Boots' management team and ensure that shareholders' interests are well served. Walgreens Boots' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Walgreens Boots' outside directors are responsible for providing unbiased perspectives on the board's policies.
Alexander Gourlay, Executive VP and President of Walgreens Co | ||
James Skinner, Executive Chairman | ||
David Brailer, Independent Director | ||
Joseph Amsbary, Senior Secretary | ||
Leonard Schaeffer, Independent Director | ||
Nancy Schlichting, Independent Director | ||
Dominic Murphy, Director | ||
Jan Reed, Senior Vice President General Counsel, Corporatye Secretary | ||
James Kehoe, Global CFO, Executive Vice President - Global | ||
Anthony Roberts, Senior Vice President Global CIO | ||
Holly May, Ex Officer | ||
Beth Leonard, Senior Officer | ||
Marco Pagni, Executive Vice President Global Chief Legal and Administrative Officer | ||
Timothy Wentworth, CEO Director | ||
John Lederer, Director | ||
Ken Murphy, Executive Vice President of Walgreens Boots Alliance and Presidentident of Global Brands | ||
Stefano Pessina, Executive Vice Chairman and CEO | ||
Simon Roberts, Executive Vice President of Walgreens Boots Alliance and President of Boots | ||
Matthew DAmbrosio, Senior Officer | ||
Rick Gates, Senior Co | ||
Neal Sample, Executive Officer | ||
Gerald Gradwell, IR Contact Officer | ||
Rosalind Brewer, CEO Director | ||
Tracey Brown, President VP | ||
Heather Dixon, Senior Vice President Chief Accounting Officer, Global Controller | ||
Kimberly Scardino, Senior Vice President Chief Accounting Officer, Global Controller | ||
Kathleen WilsonThompson, Executive Vice President Global Chief Human Resources Officer | ||
Hsiao Wang, VP Officer | ||
Jeffrey Berkowitz, Executive Vice President of Walgreens Boots Alliance and Presidentident of Pharma and Global Market Access | ||
Ornella Barra, Executive Vice President of Walgreens Boots Alliance and Presidentident and Chief Executive of Global Wholesale and International Retail | ||
Barry Rosenstein, Independent Director | ||
Mia Scholz, Sr Operations | ||
John Driscoll, Executive Healthcare | ||
Jose Almeida, Director | ||
Tiffany Kanaga, Vice Relations | ||
Janice Babiak, Independent Director | ||
Liyue Wu, Head Asia | ||
Danielle Gray, Ex Officer | ||
Manmohan Mahajan, Executive CFO | ||
Todd Heckman, Interim VP | ||
William Foote, Lead Independent Director | ||
Ginger Graham, Independent Director | ||
Aaron Radelet, Global VP | ||
Natasha Polster, Compliance Quality | ||
Aidan Clare, Senior Treasurer | ||
George Fairweather, Global CFO and Executive VP | ||
Elizabeth Burger, Executive Officer |
Walgreens Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Walgreens Boots a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Return On Equity | 4.0E-4 | ||||
Return On Asset | 0.0132 | ||||
Profit Margin | 0 % | ||||
Operating Margin | (0.0008) % | ||||
Current Valuation | 50.66 B | ||||
Shares Outstanding | 862.38 M | ||||
Shares Owned By Insiders | 17.30 % | ||||
Shares Owned By Institutions | 62.12 % | ||||
Number Of Shares Shorted | 31.16 M | ||||
Price To Earning | 8.10 X |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.MSFT | Microsoft | |
GOOG | Alphabet Class C | |
S | SentinelOne |
Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in Walgreens Boots Alliance. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of labor statistics. Note that the Walgreens Boots Alliance information on this page should be used as a complementary analysis to other Walgreens Boots' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.
Complementary Tools for Walgreens Stock analysis
When running Walgreens Boots' price analysis, check to measure Walgreens Boots' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Walgreens Boots is operating at the current time. Most of Walgreens Boots' value examination focuses on studying past and present price action to predict the probability of Walgreens Boots' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Walgreens Boots' price. Additionally, you may evaluate how the addition of Walgreens Boots to your portfolios can decrease your overall portfolio volatility.
Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
Global Correlations Find global opportunities by holding instruments from different markets | |
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
Commodity Directory Find actively traded commodities issued by global exchanges |
Is Walgreens Boots' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Walgreens Boots. If investors know Walgreens will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Walgreens Boots listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.59) | Dividend Share 1.92 | Earnings Share 0.66 | Revenue Per Share 165.003 | Quarterly Revenue Growth 0.1 |
The market value of Walgreens Boots Alliance is measured differently than its book value, which is the value of Walgreens that is recorded on the company's balance sheet. Investors also form their own opinion of Walgreens Boots' value that differs from its market value or its book value, called intrinsic value, which is Walgreens Boots' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Walgreens Boots' market value can be influenced by many factors that don't directly affect Walgreens Boots' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Walgreens Boots' value and its price as these two are different measures arrived at by different means. Investors typically determine if Walgreens Boots is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Walgreens Boots' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.